[1]
Giler Avila, C.A. and Milian Hernández, E.J. 2023. Glifozins in the treatment of type 2 diabetes: beyond the benefits in metabolic control. Anatomía Digital. 6, 1 (Jan. 2023), 49-64. DOI:https://doi.org/10.33262/anatomiadigital.v6i1.2444.